Live Webinar | hfma:content/topic/physician_paymentandreimbursement
Save
Live Webinar | Finance and Business Strategy
Save
Live Webinar | Costing and Managerial Accounting
Save
Legislative and Regulatory Update | Pricing

HFMA's Response to the ONC's RFI on Price Transparency

Legislative and Regulatory Update | Pricing

HFMA's Response to the ONC's RFI on Price Transparency

HFMA submitted a response to the Office of the National Coordinator for Health Information Technology's request for information (RFI) related to price transparency put forward in the proposed “21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program.” Regarding specific topics contained in the RFI, HFMA provided recommendations pertaining to:

  • Price Estimates for Insured Patients
  • Price Estimates for Uninsured Patients
  • Giving Price Estimates in a Timely Manner
  • Disclosing Privately Negotiated Rates Publicly
  • Empowering Clinicians with Price Information

Download the comment letter

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Pricing

Blog | Medicare Payment and Reimbursement

Research examines whether financial challenges facing hospitals with large Medicare populations lead indirectly to cost shifting

Harvard researchers found evidence to suggest that hospitals with large shares of Medicare patients are at greater risk of being acquired, which can skew the market structure and lead to higher commercial prices.

Blog | Contracting

Study: In price negotiations with hospitals, self-insured employers lack leverage

The vast difference in market power between hospitals and employers leaves the latter group with little recourse in negotiations, according to a new study.

How To | Cost Effectiveness of Health

Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study

University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.

News | Price Transparency

Congress seeks stepped-up hospital price transparency enforcement as compliance issues continue to emerge

The bipartisan leadership of a congressional committee is urging HHS to enforce price transparency rules more stringently.